16017-64-4 Usage
General Description
The chemical 2-{4-[(4-methylphenyl)sulfonyl]piperazino}-1-ethanol, also known as pimethixene, is a medication primarily used to treat anxiety and tension. It belongs to the class of drugs known as phenothiazines, which act on the central nervous system to produce their therapeutic effects. Pimethixene works by blocking the action of certain chemicals in the brain, specifically dopamine and serotonin, which are involved in the regulation of mood and anxiety. This ultimately results in a calming effect on the individual. Pimethixene is available in oral form and is typically taken one to three times a day as prescribed by a healthcare professional. It is important to note that this medication may cause drowsiness and should not be taken with alcohol or other central nervous system depressants. Additionally, it may also have potential side effects, such as dry mouth, constipation, and blurred vision.
Check Digit Verification of cas no
The CAS Registry Mumber 16017-64-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,1 and 7 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 16017-64:
(7*1)+(6*6)+(5*0)+(4*1)+(3*7)+(2*6)+(1*4)=84
84 % 10 = 4
So 16017-64-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H20N2O3S/c1-12-2-4-13(5-3-12)19(17,18)15-8-6-14(7-9-15)10-11-16/h2-5,16H,6-11H2,1H3
16017-64-4Relevant articles and documents
DBN hexafluorophosphate salts as convenient sulfonylating and phosphonylating agents
Jones, Caroline S.,Bull, Steven D.,Williams, Jonathan M. J.
, p. 8452 - 8456 (2016/09/28)
Air-stable N-sulfonyl and N-phosphonyl DBN hexafluorophosphate salts have been synthesised under mild conditions as sulfonylating and phosphonylating agents. These salts are highly efficient in the sulfonylation and phosphonylation of a range of N- and O-nucleophiles to generate sulfonamides, sulfonate esters, phosphoramidates and phosphonate esters in good yields.
Imidazole-catalyzed monoacylation of symmetrical diamines
Verma, Sanjeev K.,Acharya,Kaushik
supporting information; experimental part, p. 4232 - 4235 (2010/11/04)
Figure Presented. An imidazole-catalyzed protocol for monoacylation of symmetrical diamines has been developed. The protocol gave selective monoacylation of aliphatic (cyclic and acyclic) primary and secondary diamines. In the reaction, imidazole acts as both catalyst and a leaving group. Different monoacylated piperazines and other diamines were synthesized at room temperature in an ethanol/water solvent system.
